BamSEC and AlphaSense Join Forces
Learn More

Whitehawk Therapeutics Inc. – Material Contracts

NASDAQ: WHWK    
Share price (7/8/26): $3.96    
Market cap (7/8/26): $213 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from S-3 36 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 18 pages Form of Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 72 pages Securities Purchase Agreement by and Among Whitehawk Therapeutics, Inc., and the Purchasers May 12, 2026
12/34/56
EX-10.29
from 10-K 14 pages Whitehawk Therapeutics, Inc. Executive Employment Agreement This Executive Employment Agreement (The “Agreement”) Is Entered Into as of October 30, 2025 by and Between Whitehawk Therapeutics, Inc. (“Whitehawk”), and Margaret Dugan, M.D. (“Executive”). Whitehawk, Together With Any Subsidiaries, Shall Be Referred to in This Letter as the “Company”. 1. Duties and Scope of Employment
12/34/56
EX-10.18
from 10-K 5 pages Whitehawk Therapeutics, Inc. Amended and Restated Outside Director Compensation Policy
12/34/56
EX-10.2
from 10-Q 8 pages Whitehawk Therapeutics, Inc. $75,000,000 Common Stock Amendment No. 1 to Sales Agreement
12/34/56
EX-10.1
from 10-Q 2 pages Amendment #1 to Intellectual Property License Agreement
12/34/56
EX-10.26
from 10-K 13 pages AADI Bioscience, Inc. Executive Employment Agreement
12/34/56
EX-10.25
from 10-K 45 pages Certain Identified Information Marked With [***] Has Been Excluded From This Exhibit Because It Is Not Material and Is of the Type That the Registrant Treats as Private and Confidential. Intellectual Property License Agreement Between Wuxi Biologics (Shanghai Fx) Co., Ltd. and AADI Bioscience, Inc
12/34/56
EX-10.16
from 10-K 10 pages Whitehawk Therapeutics, Inc. 2023 Inducement Equity Incentive Plan Stock Option Agreement
12/34/56
EX-10.15
from 10-K 18 pages 4862-6160-5247.3 - 9/25/2023 10:47:15 Am Whitehawk Therapeutics, Inc. 2023 Inducement Equity Incentive Plan
12/34/56
EX-10.13
from 10-K 15 pages Whitehawk Therapeutics, Inc. 2021 Equity Incentive Plan Restricted Stock Unit Agreement Notice of Restricted Stock Unit Grant
12/34/56
EX-10.7
from 10-K 18 pages Whitehawk Therapeutics, Inc. 2021 Employee Stock Purchase Plan
12/34/56
EX-10.6
from 10-K 11 pages Whitehawk Therapeutics, Inc. 2021 Equity Incentive Plan Stock Option Agreement
12/34/56
EX-10.5
from 10-K 18 pages Whitehawk Therapeutics, Inc. 2021 Equity Incentive Plan (As Amended and Restated February 28, 2025 (The “Restatement Date”))
12/34/56
EX-10.2
from 8-K 20 pages Aadi Bioscience, Inc. 2021 Equity Incentive Plan (As Amended and Restated February 28, 2025 (The “Restatement Date”))
12/34/56
EX-10.1
from 8-K 33 pages Registration Rights Agreement
12/34/56
EX-10.3
from 8-K 18 pages Form of Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 70 pages Subscription Agreement by and Among Aadi Bioscience, Inc., and the Purchasers December 19, 2024
12/34/56
EX-10.1
from 8-K 16 pages Voting and Support Agreement
12/34/56